CTOs on the Move

Galectin Therapeutics

www.galectintherapeutics.com

 
Galectin Therapeutics (NASDAQ: GALT) is applying its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on the Company`s unique carbohydrate technology target galectin proteins which are key mediators of biologic and pathologic function.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Galectin Therapeutics raised $10M on 04/19/2021

Similar Companies

ActivX Biosciences

ActivX Biosciences is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioIntelliSense

Canarx Services

Canarx Services is a Windsor, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OnSite Waste Technologies

Save time, money and resources with the smarter, simpler, and safer way to handle regulated medical waste

Acura Pharmaceuticals

Acura Pharmaceuticals is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.